• Ovacome Home Page
• Help BEAT ovarian cancer with Ovacome
• About Ovarian Cancer
  • Symptoms of ovarian cancer
  • Types of ovarian cancer
  • Staging and grades
  • Treatment
  • Medical terminology
  • Risks
  • Screening
  • Familial ovarian cancer
  • Clinical trials
• My Ovarian Cancer
• Resources
• Community
• Support Us
• About Us
• Media
• News
• Search

Clinical trials

UKFOCSS
A trial to see if screening for people of high risk of developing ovarian cancer because of their family history is beneficial.

FOCR (the familial ovarian cancer registry)
A study to find out more about family history and ovarian cancer.

CHORUS
A trial to see if it is beneficial to have some chemotherapy prior to surgery with further chemotherapy afterwards This is a trial for people undergoing their initial treatment.

DNA Methylation
A trial to see if cell changes can help tell doctors who will respond to chemotherapy for ovarian cancer.

NEO-Escape
A trial to see if giving Paclitaxel and Carboplatin in a new way as well as including a drug called Gemcitabine makes a difference.

ICON6
A trial to see if whether adding a new drug Cediranib to standard treatment is beneficial in patients where the disease has returned more than 6 months after the intial treatment.

Ca125 doubling
A trial to see if Ca125 blood test is a reliable way to measure if treatment has been working and to see if Tamoxifen is useful in patients where the cancer has returned.

HOT11
This is a trial to see if giving oxygen therapy in a special way (hyperbaric) can help people who have suffered from long term side effects from radiotherapy damage to the pelvis.

A study looking at AZD2281 to treat cancer of the ovary
A study to see if biological therapy AZD2281 can keep the cancer at bay after the completion of chemotherapy.

GCaPPS
GCaPPS is a research study evaluating the feasibility of offering everyone over 18 in the Ashkenazi Jewish population a genetic test to identify those at increased risk of developing certain cancers ( including ovarian cancer) or passing their genes on to their children.

UKFOCCS
This study is looking at screening women who are at a high risk of developing ovarian cancer because they have a family history of cancer of the ovary or breast, or they have family members with a known genetic fault (such as BRCA 1 or BRCA 2).

AG-014699
A trial looking at a new drug for breast and ovarian cancer, in people with BRCA gene faults.